3. Myth: There’s Nothing You Can Do to Prevent Pancreatic Cancer
[5]
[5]
[5]
- Older age (over 65)
- Male sex
- African American heritage
- Type 2 diabetes or chronic pancreatitis
“Ultimately, while people cannot change their genetic predispositions, race, or age, they can actively reduce their overall risk by abstaining from tobacco use, maintaining a healthy weight, and effectively managing chronic health conditions,” says Proverbs-Singh.
4. Myth: Pancreatic Cancer Isn’t Treatable
Pancreatic cancer is difficult to treat, but that doesn’t mean it’s not treatable at all.
“Pancreatic cancer is treatable, although the best approach depends on the stage, whether the tumor can be surgically removed, its molecular characteristics, and the patient’s overall health,” says Dr. Kasi.
[6]
[6]
While radiation exposure can trigger side effects in surrounding tissue, such as nausea, stomach inflammation, or fatigue, advancements in precision imaging allow clinicians to manage radiation toxicity effectively and protect nearby organs.[7]
[8]
And even when pancreatic cancer cannot be cured, treatment may help control the disease, relieve symptoms, and help people live longer and better,” says Kasi.
5. Myth: Palliative Care Means Giving Up
[9]
“Because the disease carries a notoriously heavy symptom burden, palliative teams provide aggressive pain management, such as advanced medications and specialized nerve blocks, while offering essential digestive support through enzyme replacements, appetite stimulants, and anti-nausea medications to combat malnutrition and weight loss,” says Proverbs-Singh.
[9]
“Beyond managing bodily symptoms, palliative care provides crucial emotional and psychological support for both patients and their caregivers, acting as a bridge between various oncology specialists to ensure that every medical decision aligns with the patient’s personal goals and values,” says Proverbs-Singh.6. Myth: Clinical Trials Are a Last Resort
Clinical trials should not automatically be viewed as a last resort, says Kasi. “Depending on the study, they may be an option at different stages of pancreatic cancer, including soon after diagnosis,” he says. “Some trials are specifically designed for people who have not yet received treatment.”
Kasi encourages patients to ask about clinical trials early and whenever treatment decisions are being made. “Eligibility can depend on cancer stage, previous treatments, overall health, and specific genetic or molecular features of the tumor,” he says.
[10]
